GPR84 ANTAGONIST is under patent filing
ONTOCHEM AND INFARMATIK, INC. jointly started a reporter gene assay based GPCR property screening of INFARMATIK, INC. fragments set. The primary results on D1 and human adrenerg beta2 receptors of the reporter gene assay is to reported in Basel FBLD2014 and copies of the poster is internet published and distributed shortly afterwards.
The results on GPR84 looks to be promising and was further investigated in other assays. The findings were not published in details since they could be used in a patent application for antiinflammatory agent and related pharmacological use.
Patent under preparation submitted by ONTOCHEM GMBH.
If interested write us an email.